Medinotec (MDNC) Common Equity (2022 - 2026)

Medinotec has reported Common Equity for 5 years, with the latest figure at $5.7 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 33.73% year-over-year to $5.7 million; the trailing twelve-month figure through Feb 2026 stood at $5.7 million (up 33.73% YoY), and the FY2026 full-year result was $5.7 million, up 33.73% from the prior year.
• Common Equity for Q1 2026 stood at $5.7 million, up from $5.5 million in the prior quarter.
• The five-year high for Common Equity was $5.7 million in Q1 2026, with the low at -$469985.0 in Q1 2022.
• Historically, Common Equity has averaged $2.7 million across 5 years, with a median of $2.6 million in 2023.
• Annual changes were most pronounced in 2023 — Common Equity surged 4781.9% — and 2024, when it declined 15.21%.
• Medinotec's Common Equity stood at $42509.0 in 2022, then surged by 4781.9% to $2.1 million in 2023, then surged by 36.17% to $2.8 million in 2024, then surged by 94.64% to $5.5 million in 2025, then grew by 3.84% to $5.7 million in 2026.
• The last three Common Equity figures came in at $5.7 million (Q1 2026), $5.5 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.